Silverback Therapeutics is a clinical-stage biopharmaceutical company leveraging their proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases
Silverback Therapeutics is a clinical-stage biopharmaceutical company leveraging their proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.